NFKB1 and adenocarcinoma: Compared to C1 type characterized by low enrichment of NF-κB signaling pathway, C2 type had more high-grade samples, more advanced cases, and less adenocarcinoma proportion (Figure 2(b)), indicating that NF-κB signaling pathway was involved in a worse phenotype.